查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1683254

全球即时传染病检测市场研究报告 - 产业分析、规模、份额、成长、趋势及预测 2025 至 2033 年

Global Point of Care Infectious Disease Testing Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 157 Pages | 商品交期: 最快1-2个工作天内

价格

全球即时传染病检测市场规模预计将从 2024 年的 175.5 亿美元增长到 2033 年的 271.5 亿美元，在 2026 年至 2033 年的预测期内呈现 4.97% 的强劲年复合成长率(CAGR)。

面对日益增多的传染病，对快速且准确的诊断解决方案的需求不断增加，推动全球即时诊断（POC）传染病检测市场有望大幅成长。 COVID-19 疫情凸显了及时检测对于控制疫情和有效管理公共卫生的迫切必要性。 POC 测试的优点在于可以在几分钟内提供结果，使医疗保健提供者能够快速做出明智的决定并进行适当的治疗。随着对传染病早期发现和预防的关注度不断提高，POC 检测解决方案的采用预计将加速，从而促进这一重要市场的创新和投资。

此外，技术的进步将改变 POC 传染病检测格局。分子诊断、微流体和生物感测器的整合提高了测试的敏感性和特异性，可以检测多种病原体，包括细菌、病毒和寄生虫。此外，可以在诊所到偏远地区等各种环境中操作的用户友好型设备的开发正在扩大检测管道。随着医疗保健系统越来越重视分散式测试方法，对能够即时提供准确结果的创新 POC 解决方案的需求将持续上升。

此外，对个人化医疗的日益重视和对全球健康计划的日益关注预计将塑造POC传染病检测市场的未来。随着医疗保健提供者寻求根据个别患者的需求制定治疗方案，对能够为临床决策提供参考的快速诊断工具的需求变得至关重要。 POC 测试符合这一趋势，使医疗保健专业人员能够快速评估患者的状况并相应地调整治疗计划。此外，旨在对抗传染病的全球卫生计画（特别是在资源匮乏的环境中）正在推动对可在不同环境中部署的 POC 测试技术的投资。诊断製造商、医疗保健组织和公共卫生机构之间的协作努力对于推动这些解决方案至关重要，确保 POC 传染病检测市场保持敏捷并能应对新出现的健康挑战。

我们的报告经过精心製作，为客户提供有关各个行业和市场的全面且可操作的见解。每份报告都包含几个关键部分，以确保彻底了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本节探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准将市场细分为不同的细分市场。该分析强调了每个部分的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本节深入介绍领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，预测特定时期内的市场规模和成长趋势。这包括定量分析和图形表示来说明未来的市场轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前和新兴的市场趋势、技术创新和潜在投资领域。本节提供未来市场发展和成长前景的见解。

目录

第 1 章：前言

  • 报告描述
    • 客观的
    • 目标受众
    • 独特销售主张 (USP) 产品
  • 研究范围
  • 研究方法
    • 市场研究流程
    • 市场研究方法

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：即时诊断传染病检测产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 依疾病进行市场吸引力分析
    • 按最终用途进行的市场吸引力分析
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料製造商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球即时传染病检测市场分析：依疾病分类

  • 疾病概览
  • 历史和预测数据
  • 疾病分析
  • 爱滋病毒阳性检测结果
  • 艰难梭菌 POC
  • 乙肝病毒阳性检测结果
  • 肺炎或链球菌相关感染
  • 呼吸道合胞病毒 (RSV) POC
  • HPV 阳性结果
  • 流感/流感 POC
  • 丙型肝炎病毒
  • 抗甲氧西林金黄色葡萄球菌
  • 结核病和抗药性结核病 POC
  • HSV（单纯疱疹病毒） POC
  • 其他传染病 POC

第 6 章：全球即时传染病检测市场分析：依最终用途

  • 按最终用途概述
  • 历史和预测数据
  • 按最终用途分析
  • 医院
  • 诊所
  • 家
  • 辅助生活医疗设施
  • 实验室
  • 其他的

第 7 章：全球即时诊断传染病检测市场分析：按地区划分

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概述、历史和预测数据销售分析
    • 北美各细分市场销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测数据销售分析
    • 欧洲各细分市场销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测数据销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测数据销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东非洲销售分析
    • 概述、历史和预测数据销售分析
    • 中东非洲分部销售分析
    • 中东非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第 8 章：即时诊断传染病检测公司的竞争格局

  • 传染病即时检测市场竞争
  • 伙伴关係/合作/协议
  • 合併与收购
  • 新产品发布
  • 其他进展

第九章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Alere
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Thermo Fisher Scientific Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • F. Hoffmann-La Roche Ltd
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Siemens Healthineers
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BD Company
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Chembio Diagnostics Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Trinity Biotech
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Cardinal Health
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Quest Diagnostics Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bio-Rad Labs Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BioMéRieux SA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sight Diagnostics Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Gene POC
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Trivitron Healthcare
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • OJ-Bio Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Ortho-Clinical Diagnostics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

Product Code: VMR11212341

Global Point of Care Infectious Disease Testing Market size is anticipated to grow from USD 17.55 Billion in 2024 to USD 27.15 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 4.97% during the forecast period of 2026 to 2033.

The global point of care (POC) infectious disease testing market is poised for significant growth, driven by the increasing demand for rapid and accurate diagnostic solutions in the face of rising infectious diseases. The COVID-19 pandemic has underscored the critical need for timely testing to control outbreaks and manage public health effectively. POC testing offers the advantage of delivering results within minutes, enabling healthcare providers to make informed decisions quickly and initiate appropriate treatment. As the focus on early detection and prevention of infectious diseases intensifies, the adoption of POC testing solutions is expected to accelerate, fostering innovation and investment in this vital market.

Moreover, advancements in technology are set to transform the POC infectious disease testing landscape. The integration of molecular diagnostics, microfluidics, and biosensors is enhancing the sensitivity and specificity of tests, allowing for the detection of a wide range of pathogens, including bacteria, viruses, and parasites. Additionally, the development of user-friendly devices that can be operated in various settings, from clinics to remote locations, is expanding access to testing. As healthcare systems increasingly prioritize decentralized testing approaches, the demand for innovative POC solutions that can deliver accurate results in real-time will continue to rise.

In addition, the growing emphasis on personalized medicine and the increasing focus on global health initiatives are expected to shape the future of the POC infectious disease testing market . As healthcare providers seek to tailor treatments to individual patient needs, the demand for rapid diagnostic tools that can inform clinical decisions is becoming paramount. POC testing aligns with this trend by enabling healthcare professionals to quickly assess a patient's condition and adjust treatment plans accordingly. Furthermore, global health initiatives aimed at combating infectious diseases, particularly in low-resource settings, are driving investments in POC testing technologies that can be deployed in diverse environments. Collaborative efforts between diagnostic manufacturers, healthcare organizations, and public health agencies will be essential in advancing these solutions, ensuring that the POC infectious disease testing market remains agile and responsive to emerging health challenges.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Technology

  • Lateral Flow Immunoassay
  • Agglutination Test
  • Flow-through test/Immunoconcentration Assay
  • Molecular Diagnostics
  • Others

By Disease

  • HIV POC
  • Clostridium Difficile POC
  • HBV POC
  • Pneumonia Or Streptococcus Associated Infections
  • Respiratory Syncytial Virus (RSV) POC
  • HPV POC
  • Influenza/Flu POC
  • HCV POC
  • MRSA POC
  • TB & Drug-resistant TB POC
  • HSV POC
  • COVID-19
  • Others

By End Use

  • Clinics
  • Hospitals
  • Home
  • Assisted Living Healthcare Facilities
  • Laboratory
  • COMPANIES PROFILED
  • Abbott
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers
  • Becton
  • Dickinson & Company
  • Chembio Diagnostics Inc.
  • Trinity Biotech
  • Cardinal Health
  • Quest Diagnostics Incorporated
  • Bio-Rad Laboratories Inc.
  • bioMerieux SA
  • Sight Diagnostics Ltd.
  • Gene POC
  • Trivitron Healthcare
  • OJ-Bio Ltd.
  • Ortho-Clinical Diagnostics
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. POINT OF CARE INFECTIOUS DISEASE TESTING INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Disease
    • 3.7.2 Market Attractiveness Analysis By End-Use
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET ANALYSIS BY DISEASE

  • 5.1. Overview By Disease
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Disease
  • 5.4. HIV POC Historic and Forecast Sales By Regions
  • 5.5. Clostridium difficile POC Historic and Forecast Sales By Regions
  • 5.6. HBV POC Historic and Forecast Sales By Regions
  • 5.7. Pneumonia or Streptococcus associated infections Historic and Forecast Sales By Regions
  • 5.8. Respiratory syncytial virus (RSV) POC Historic and Forecast Sales By Regions
  • 5.9. HPV POC Historic and Forecast Sales By Regions
  • 5.10. Influenza/Flu POC Historic and Forecast Sales By Regions
  • 5.11. HCV POC Historic and Forecast Sales By Regions
  • 5.12. MRSA POC Historic and Forecast Sales By Regions
  • 5.13. TB and drug-resistant TB POC Historic and Forecast Sales By Regions
  • 5.14. HSV (Herpes Simplex Virus) POC Historic and Forecast Sales By Regions
  • 5.15. Other infectious disease POC Historic and Forecast Sales By Regions

6. GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET ANALYSIS BY END-USE

  • 6.1. Overview By End-Use
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By End-Use
  • 6.4. Hospitals Historic and Forecast Sales By Regions
  • 6.5. Clinics Historic and Forecast Sales By Regions
  • 6.6. Home Historic and Forecast Sales By Regions
  • 6.7. Assisted Living Healthcare Facilities Historic and Forecast Sales By Regions
  • 6.8. Laboratories Historic and Forecast Sales By Regions
  • 6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East Africa By Segment Sales Analysis
    • 7.7.3 Middle East Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE POINT OF CARE INFECTIOUS DISEASE TESTING COMPANIES

  • 8.1. Point of Care Infectious Disease Testing Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF POINT OF CARE INFECTIOUS DISEASE TESTING INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Alere
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Thermo Fisher Scientific Inc
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. F. Hoffmann-La Roche Ltd
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Siemens Healthineers
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. BD Company
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Chembio Diagnostics Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Trinity Biotech
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Cardinal Health
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Quest Diagnostics Inc.
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Bio-Rad Labs Inc.
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. BioMéRieux SA
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. Sight Diagnostics Ltd.
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments
  • 9.15. Gene POC
    • 9.15.1 Company Overview
    • 9.15.2 Company Revenue
    • 9.15.3 Products
    • 9.15.4 Recent Developments
  • 9.16. Trivitron Healthcare
    • 9.16.1 Company Overview
    • 9.16.2 Company Revenue
    • 9.16.3 Products
    • 9.16.4 Recent Developments
  • 9.17. OJ-Bio Ltd.
    • 9.17.1 Company Overview
    • 9.17.2 Company Revenue
    • 9.17.3 Products
    • 9.17.4 Recent Developments
  • 9.18. Ortho-Clinical Diagnostics
    • 9.18.1 Company Overview
    • 9.18.2 Company Revenue
    • 9.18.3 Products
    • 9.18.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Disease (USD MN)
  • HIV POC Market Sales By Geography (USD MN)
  • Clostridium difficile POC Market Sales By Geography (USD MN)
  • HBV POC Market Sales By Geography (USD MN)
  • Pneumonia or Streptococcus associated infections Market Sales By Geography (USD MN)
  • Respiratory syncytial virus (RSV) POC Market Sales By Geography (USD MN)
  • HPV POC Market Sales By Geography (USD MN)
  • Influenza/Flu POC Market Sales By Geography (USD MN)
  • HCV POC Market Sales By Geography (USD MN)
  • MRSA POC Market Sales By Geography (USD MN)
  • TB and drug-resistant TB POC Market Sales By Geography (USD MN)
  • HSV (Herpes Simplex Virus) POC Market Sales By Geography (USD MN)
  • Other infectious disease POC Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Home Market Sales By Geography (USD MN)
  • Assisted Living Healthcare Facilities Market Sales By Geography (USD MN)
  • Laboratories Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Point of Care Infectious Disease Testing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Point of Care Infectious Disease Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global Point of Care Infectious Disease Testing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Disease
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Disease (USD MN)
  • HIV POC Market Sales By Geography (USD MN)
  • Clostridium difficile POC Market Sales By Geography (USD MN)
  • HBV POC Market Sales By Geography (USD MN)
  • Pneumonia or Streptococcus associated infections Market Sales By Geography (USD MN)
  • Respiratory syncytial virus (RSV) POC Market Sales By Geography (USD MN)
  • HPV POC Market Sales By Geography (USD MN)
  • Influenza/Flu POC Market Sales By Geography (USD MN)
  • HCV POC Market Sales By Geography (USD MN)
  • MRSA POC Market Sales By Geography (USD MN)
  • TB and drug-resistant TB POC Market Sales By Geography (USD MN)
  • HSV (Herpes Simplex Virus) POC Market Sales By Geography (USD MN)
  • Other infectious disease POC Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Home Market Sales By Geography (USD MN)
  • Assisted Living Healthcare Facilities Market Sales By Geography (USD MN)
  • Laboratories Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.